Article
The Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling
10 Mar 2022
Abstract excerpt
Glioblastoma (GBM) is a malignant tumor with a median survival rate of 15-16 months with standard care; however, cases of successful treatment offer hope that an enhanced understanding of the pathology will improve the prognosis. The cell of origin in GBM remains controversial. Recent evidence has implicated stem cells as cells of origin in many cancers. Neural stem/precursor cells (NSCs) are being evaluated as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
